Introduction to IPO

Chapter 20

Key IPO Performance Indicators

KPIs, or Key Performance Indicators, are essential metrics that provide a snapshot of a company's business performance over a specific period. These metrics are crucial for both the company and its investors. By looking at KPIs, companies can identify their strengths and address areas needing improvement, while investors can make more informed investment decisions.

Different KPIs reveal various aspects of a company's profitability, efficiency, liquidity, and operations. It’s important to understand that no single KPI can give a complete picture of a company's health. Analyzing multiple KPIs provides a more comprehensive understanding.

Let's dive into some common KPIs that companies use to assess their performance:

1. Understanding Revenue from Operations

Revenue from operations reflects the income a company earns from its main business activities. This includes the earnings from selling products or services but excludes income from other sources like investments or one-time gains. Often referred to as the "top line," this figure is crucial for gauging sales performance.

The primary focus is on the growth percentage of this revenue, as a growing turnover indicates a thriving company. For instance, Mukka Proteins Limited has shown significant revenue growth over the years:

Mukka Proteins Limited KPIs

Mar-23Mar-22Mar-21Mar-20
Revenue from Operations (Rs. in crores)1177770604549
Growth in Revenue/Sales Growth (%)52.85%27.48%10.01%

Points to Consider:

  • An increasing growth percentage is a positive indicator.
  • Consistent growth, while positive, might suggest limited sales expansion.
  • A declining growth rate is a red flag.

2. Exploring Profit After Tax

Profit After Tax (PAT) is the net income left after all expenses and taxes have been paid. This figure is crucial for evaluating a company’s financial health, often referred to as the "bottom line." A higher PAT suggests efficient expense management and strong profitability.

PAT is derived by subtracting taxes and all other expenses from total income. A positive PAT indicates profitability, while a negative PAT denotes losses.

Mukka Proteins PAT

Mar-23Mar-22Mar-21Mar-20
Profit After TaxRs 47.53 CrRs 25.82 CrRs 11.01 CrRs 14.00 Cr

Points to Consider:

  • An increase in PAT is a strong positive sign.
  • Consistent PAT is good, but should be monitored for potential growth.
  • A decrease in PAT warrants caution.
  • Sudden fluctuations might be one-time events; investigate the cause.

3. Delving into Profit After Tax Margin (PAT Margin)

The PAT Margin is expressed as a percentage of PAT against the company’s revenue from operations. This metric indicates how much of the company's sales translate into profit. A higher PAT Margin is a positive indicator of a company’s ability to manage costs and taxes effectively.

Mukka Proteins PAT Margin

Mar-23Mar-22Mar-21Mar-20
PAT Margin4.04%3.35%1.82%2.55%

Points to Consider:

  • A higher PAT Margin is very favorable.
  • A lower margin might still be acceptable but needs monitoring.
  • Negative margins are concerning.
  • Investigate significant changes for underlying causes.

4. Assessing Return on Capital Employed (RoCE)

Return on Capital Employed (RoCE) evaluates a company's profitability in relation to its total capital. It serves as a benchmark for investors to determine the efficiency of a company in generating profits from its capital.

RoCE is calculated by dividing operating profit by capital employed (total assets minus current liabilities). A higher RoCE is generally preferable, with 15-20% being considered good, though it varies by industry.

Mukka Proteins RoCE

Mar-23Mar-22Mar-21
RoCE17.62%13.86%5.86%

Points to Consider:

  • An increasing RoCE is highly favorable.
  • Consistent RoCE is positive but may lack growth.
  • Decreasing RoCE is a warning sign.
  • Analyze sudden changes for potential anomalies.

5. Examining Return on Equity (RoE)

Return on Equity (RoE) is another profitability metric that assesses a company's ability to generate profits from its equity. Unlike RoCE, RoE focuses solely on equity, excluding debt.

Calculated by dividing net profit by shareholder's equity, a higher RoE is generally better. However, industry norms should be considered, as RoE can vary significantly.

Mukka Proteins ROE

Mar-23Mar-22Mar-21
RoE36.71%30.00%17.37%

Points to Consider:

  • An increasing RoE is a very positive sign.
  • Consistent RoE is positive but may indicate limited growth.
  • Decreasing RoE is a cautionary signal.
  • Consider debt levels and other factors alongside RoE.

6. Analyzing Return on Net Worth (RONW%)

Return on Net Worth (RONW) measures a company’s profitability relative to its net assets, including equity and reserves. This ratio indicates how effectively a company utilizes its assets to generate profits.

RONW is calculated by dividing net income by shareholders' equity. A higher RONW is generally favorable.

Mukka Proteins RONW

Mar-23Mar-22Mar-21
RONW34.19%27.75%13.91%

Points to Consider:

  • An increasing RONW is a strong positive sign.
  • A consistent RONW is good but could imply a lack of growth.
  • A decreasing RONW is a warning sign.
  • Investigate sudden changes for underlying reasons.

7. Understanding Debt to Equity Ratio

The Debt to Equity Ratio provides insights into a company’s capital structure, indicating how much debt versus equity is used for financing. A high ratio suggests reliance on debt, which can be risky if the company struggles to meet its obligations.

An ideal debt-equity ratio varies by industry, typically between 1 and 1.5 to 2. Capital-intensive industries might have higher ratios.

Mukka Proteins Debt to Equity Ratio

Mar-23Mar-22Mar-21
Debt Equity Ratio1.641.682.31

Points to Consider:

  • A debt-equity ratio between 1-1.5 is generally good.
  • Some industries naturally have higher ratios.
  • A decreasing trend is favorable.
  • An increasing trend is a cautionary sign.

8. Discovering Earnings per Share (EPS)

Earnings per Share (EPS) is a key profitability metric indicating how much profit is allocated to each share. This metric helps investors assess a company's performance.

EPS is derived by dividing net profit by the total number of outstanding shares. There are two types: basic EPS and diluted EPS. Diluted EPS accounts for convertible securities, while basic EPS does not.

Mukka Proteins Earnings Per Share

Mar-23Mar-22Mar-21
EPS21.10.41

Points to Consider:

  • An increasing EPS is a very positive sign.
  • A consistent EPS is positive but may indicate limited growth.
  • A decreasing EPS is a cautionary signal.

9. Evaluating Price to Earnings Ratio (PE Ratio)

The Price to Earnings Ratio (P/E) is crucial for assessing a company's stock valuation. It helps determine if a stock is undervalued or overvalued by comparing the current share price with EPS.

A P/E ratio is calculated by dividing the current share price by EPS. A lower P/E ratio is generally better, indicating a more reasonably priced stock. However, industry norms and future growth potential should be considered.

Mukka Proteins PE Ratio (Upper Price Band of Rs. 28)

Mar-23Mar-22Mar-21
PE1425.4568.29

Points to Consider:

  • A lower P/E ratio suggests a reasonably priced stock.
  • A higher P/E ratio indicates an overpriced stock.

10. Exploring EBITDA Margin

The EBITDA Margin measures a company's operating profitability. EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. This margin provides insight into a company's operational efficiency.

To calculate the EBITDA margin, add finance costs, tax expense, and depreciation and amortization to PAT, then divide by revenue from operations. A margin of 10% or above is generally favorable.

Mukka Proteins EBITDA Margin

Mar-23Mar-22Mar-21
EBITDA Margin8.01%7.04%5.27%

Points to Consider:

  • An increasing EBITDA margin is a positive sign.
  • A decreasing trend warrants caution.

11. Understanding Price to Book Value

The Price to Book Value (P/B) ratio assesses whether a stock is undervalued or overvalued by comparing the market value of equity to its book value. A higher P/B ratio indicates overvaluation, while a lower ratio suggests undervaluation.

Calculated by dividing the market price per share by the net asset value per share, a P/B ratio of 1-3 is generally considered undervalued, although this varies by industry.

Mukka Proteins P/B Ratio

Mar-23
P/BV4.78

Points to Consider:

  • A P/B ratio of 1-3 indicates undervaluation.
  • A P/B ratio of more than 15 suggests overvaluation.
  • Compare P/B ratios with industry peers for a better understanding.

12. Grasping Market Capitalization

Market Capitalization, or Market Cap, represents the total market value of a company’s outstanding shares. It is a key metric for understanding the size and value of a company in the stock market.

Companies are categorized into large cap, mid cap, and small cap based on their market cap. Large cap companies (Rs 20,000 crore or more) are considered stable, while small cap companies (below Rs 5,000 crore) offer high growth potential but with higher risk.

How to Calculate Market Capitalization

Market Cap = Current Share Price × Total Number of Outstanding Shares

Example: Mukka Protein IPO

  • Outstanding shares: 30,00,00,000 (Rs 30 crore)
  • Price band: Rs 26-28

Market Cap (At upper price band) = 30 crore * 28/share = Rs 840 crore

Example: JSW Cement IPO

  • Outstanding shares: 1,36,33,64,936
  • Price band: Rs 139-147

Market Cap = 1363364936 * 147 = Rs 20,041.46 Crore

A higher market capitalization indicates a large cap company, often seen as more stable and attractive to investors.

13. KPI Analysis

To understand these metrics better, let's explore Mukka Protein's KPIs. Here's what the data reveals about the company:

Mukka Proteins KPI Analysis

Mar 23Mar 22Mar 21KPI Analysis
Revenue from Operations (Rs. in crore)1177770604Increasing revenue is a positive indicator.
Growth in Revenue/Sales Growth (%)52.85%27.48%10.01%Rising sales growth is beneficial.
Profit After Tax (Rs. in crore)47.5325.8211.01Increasing PAT is favorable.
PAT Margin (%)4.04%3.35%1.82%Growing PAT Margin is positive.
RoCE (%)17.62%13.86%5.86%Rising RoCE is advantageous.
RoE (%)36.71%30.00%17.37%Increasing RoE is beneficial.
RoNW (%)34.19%27.75%13.91%Rising RoNW is favorable.
Debt/Equity Ratio1.641.682.31A decreasing ratio is advantageous.
P/E1425.4568.29Improving P/E is positive.
EPS21.10.41Rising EPS is favorable.
EBITDA Margin8.01%7.04%5.27%Increasing margin is a good sign.
P/BV4.78Fairly priced.

Therefore, based on the analysis of financial KPIs, applying for Mukka Proteins could be promising. However, it’s crucial to consider other factors like company reviews, sector growth, the object of the issue, and the management team before making an investment decision.

Key Takeaways

KPIs are instrumental in assessing a company's performance, determining its profitability and efficiency. They assist investors in deciding whether to invest in an IPO. It’s crucial to review all metrics, analyze trends, and compare them with industry peers for a well-rounded evaluation.

Frequently Asked Questions

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.